Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-ENaC for Treatment of Cystic Fibrosis网页链接 $Arrowhead制药(ARWR)$ $福泰制药(VRTX)$